Skip to main content
. 2016 Feb 18;11(2):e0148628. doi: 10.1371/journal.pone.0148628

Table 2. Demographic information for the 5 human subjects imaged with 18F-FSPG.

Subject Sex Age Pathology Prior treatment (months before) 18F-FSPG Dose (MBq)
1 F 29 Grade 2 oligodendroglioma Subtotal resection (11) 327
2 F 45 Grade 4 glioblastoma Gamma knife (4) 304
3 M 64 Metastatic NSCLC Cyberknife (7) 244
4 F 49 Metastatic NSCLC Chemotherapy (1) 312
5 M 65 Metastatic NSCLC - 303